Cite

HARVARD Citation

    Arijs, I. et al. (2018). Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC. Gut. 67 (1), pp. 43-52. [Online]. 
  
Back to record